KYNTRA BIO, INC. Other Current Assets
KYNTRA BIO, INC. (KYNB) had Other Current Assets of $833.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Other Assets, Current $833.00K.
- 2026-03-31: Other Assets, Current $556.00K.
- 2025-12-31: Other Assets, Current $1.12M.
- 2025-09-30: Other Assets, Current $695.00K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $833.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $556.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $1.12M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $695.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.27M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $1.26M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $1.14M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $3.19M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $3.59M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $1.87M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $6.68M 10-K · filed 2025-03-17 | $6.71M 10-K · filed 2024-02-26 |
| 2022-12-31 | $4.35M 10-K · filed 2024-02-26 | |
| 2021-12-31 | $5.07M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $7.09M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.31M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $2.52M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $1.81M 10-K/A · filed 2022-03-04 | |
| 2020-09-30 | $6.01M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.05M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $2.20M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.72M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $3.65M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $3.90M 10-Q · filed 2019-08-08 | |
| 2018-12-31 | $2.22M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |